Graphite Bio - Delisted Stock
It looks like this equity (GRPH) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check LENZ LENZ Therapeutics to make sure you are using current equity.
Graphite Bio cannot be verified against its exchange. It appears that Graphite Bio is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Note that a delisted financial instrument is a security that has been removed from its exchange and is no longer traded publicly. This can occur for various reasons, such as bankruptcy, merger, or failure to meet exchange listing requirements. Delisted instruments can still trade in the over-the-counter (OTC) market, but they are typically less liquid and carry higher risk compared to assets listed on a major exchange. Check all delisted instruments accross multiple markets.
Graphite Bio Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Graphite Bio market risk premium is the additional return an investor will receive from holding Graphite Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Graphite Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Graphite Bio's alpha and beta are two of the key measurements used to evaluate Graphite Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 41.58 | |||
| Semi Deviation | 10.45 | |||
| Standard Deviation | 171.86 | |||
| Variance | 29536.76 |
Try Other Suggestions
Delisting Warning - GRPH
Graphite Bio was delisted
| The entity Graphite Bio with a symbol GRPH was delisted from NASDAQ Exchange. Please try LENZ Therapeutics with a symbol LENZ from now on. Check all delisted instruments accross multiple markets. |
Graphite Bio Corporate Management
Elected by the shareholders, the Graphite Bio's board of directors comprises two types of representatives: Graphite Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Graphite. The board's role is to monitor Graphite Bio's management team and ensure that shareholders' interests are well served. Graphite Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Graphite Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Yao | Vice Relations | Profile | |
| Christine PMP | Chief Operations | Profile | |
| Jerry Cacia | Chief Officer | Profile | |
| MD FACC | CEO Pres | Profile | |
| Alethia Young | Chief Officer | Profile |
Still Interested in Graphite Bio?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |